Motley Fool article is a good read. What Should
Post# of 148154
What Should Investors Make Of Conflicting Results Surrounding Gilead's Remdesivir?
There's a lot riding on the success of the company's potential treatment for COVID-19.
https://www.fool.com/investing/2020/05/02/wha...sults.aspx